FULC FULCRUM THERAPEUTICS INC

Ownership history in WOLVERINE TRADING, LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in FULCRUM THERAPEUTICS INC (FULC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 16,400 -24,900 -60.3% 0.00% $116K $6.88
2024 Q4 ADDED 41,300 +24,300 +142.9% 0.00% $193K $4.70
2024 Q3 REDUCED 17,000 -35,100 -67.4% 0.00% $64K $3.57
2024 Q3 ADDED 52,100 +39,400 +310.2% 0.00% $196K $3.57
2024 Q2 REDUCED 12,700 -25,300 -66.6% 0.00% $79K $6.20
2024 Q2 ADDED 38,000 +14,421 +61.2% 0.00% $236K $6.20
2024 Q1 REDUCED 23,579 -11,921 -33.6% 0.00% $223K $9.44
2024 Q1 ADDED 35,500 +21,753 +158.2% 0.00% $335K $9.44
2023 Q4 REDUCED 13,747 -7,953 -36.6% 0.00% $93K $6.75
2023 Q4 ADDED 21,700 +6,100 +39.1% 0.00% $146K $6.75
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FULC price (monthly, adj. close)
← Back to WOLVERINE TRADING, LLC Holdings